Health Trials

Endocrine Disruption, Menopause, and Poor Sleep in wOmen With Type 2 Diabetes: Effects on Cardiovascular Health

ConditionsMenopauseSleep DisruptionT2DM
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age48-58
SponsorOttawa Heart Institute Research Corporation

About this trial

EMPOWER aims to determine the overall effect of menopause and sleep disruption on cardiac remodeling in women with type 2 diabetes.

Eligibility criteria

Qualifiers

Female Sex

Age range 48-58 years

In menopausal transition phase (pre-menopause or peri-menopause)

Diagnosis of Type 2 Diabetes Mellitus

Disqualifiers

Male Sex

Currently Pregnant

Prior history of total hysterectomy or bilateral oophorectomy

Trial design

Treatments tested in this trial

  • 4 years of clinical evaluations.

Treatment groups

381 Participants
are divided into 1 treatment group

Locations

This trial has no locations

Sponsors and collaborators

Ottawa Heart Institute Research Corporation

Lead sponsor

Source ClinicalTrials.gov